Yorktown Management & Research Company’s Neurocrine Biosciences NBIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-2,850
| Closed | -$315K | – | 230 |
|
|
2025
Q1 | $315K | Hold |
2,850
| – | – | 0.34% | 136 |
|
|
2024
Q4 | $389K | Hold |
2,850
| – | – | 0.37% | 124 |
|
|
2024
Q3 | $328K | Buy |
+2,850
| New | +$328K | 0.34% | 155 |
|
|
2021
Q2 | – | Sell |
-2,500
| Closed | -$243K | – | 256 |
|
|
2021
Q1 | $243K | Hold |
2,500
| – | – | 0.2% | 197 |
|
|
2020
Q4 | $240K | Hold |
2,500
| – | – | 0.22% | 206 |
|
|
2020
Q3 | $240K | Hold |
2,500
| – | – | 0.22% | 229 |
|
|
2020
Q2 | $305K | Buy |
+2,500
| New | +$305K | 0.27% | 183 |
|